Abstract:Early studies1Chen N Zhou M Dong X et al.Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.Lancet. 2020; 395: 507-513Summary Full Text Full Text PDF PubMed Scopus (14440) Google Scholar, 2Wang D Hu B Hu C et al.Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China.JAMA. 2020; (published online Feb 7.)DOI:10.1001/jama.2020.1585Crossref Scopus (16307) Google Scholar of coronavirus disease 2019 (COVID-19) reported that the proportion of patients presenting with gastrointestinal symptoms was low. However, evidence for enteric involvement is emerging.3Holshue ML DeBolt C Lindquist S et al.First case of 2019 novel coronavirus in the United States.N Engl J Med. 2020; 382: 929-936Crossref PubMed Scopus (4303) Google Scholar, 4Zhang W Du RH Li B et al.Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes.Emerg Microbes Infect. 2020; 9: 386-389Crossref PubMed Scopus (1326) Google Scholar, 5Wang W Xu Y Gao R et al.Detection of SARS-CoV-2 in different types of clinical specimens.JAMA. 2020; (published online March 11.)DOI:10.1001/jama.2020.3786Crossref Scopus (3798) Google Scholar, 6Xiao F Tang M Zheng X Liu Y Li X Shan H Evidence for gastrointestinal infection of SARS-CoV-2.Gastroenterology. 2020; (published online March 3.)DOI:10.1053/j.gastro.2020.02.055Summary Full Text Full Text PDF Scopus (2024) Google Scholar Recently, a multicentre study7Pan L Mu M Yang P et al.Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study.Am J Gastroenterol. 2020; (published online March 18, 2020.) (preprint).https://journals.lww.com/ajg/Documents/COVID_Digestive_Symptoms_AJG_Preproof.pdf?PRID=AJG_PR_031820Crossref PubMed Scopus (1200) Google Scholar in Hubei province (China) indicated that gastrointestinal symptoms were common in patients with COVID-19. We examined the intestinal symptoms of patients with COVID-19 from multiple medical centres located in and outside of Hubei province. We retrospectively analysed data from 232 patients who were positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA admitted to 14 hospitals (two hospitals in Guangdong province, two in Hubei province, and ten in Jiangxi province) between Jan 19, 2020, and March 6, 2020. Most patients were admitted because of fever, cough, dyspnoea, and chest CT findings consistent with COVID-19 pneumonia. Diagnosis of COVID-19 was based on positive SARS-CoV-2 RNA tests. Two patients with pre-existing digestive diseases were excluded from our analysis. The analysis was approved by the institutional review boards of Sun Yat-sen University and the participating hospitals. Full details of the methods used are in the appendix (p 1). The clinical and demographic characteristics of the 230 patients analysed are shown in the appendix (p 2). There were 129 men and 101 women; median age was 47·5 years (range 7–90). The most common symptoms at onset of illness were fever (193 [84%] patients), cough (159 [69%] patients), and sputum production (98 [43%] patients). Diarrhoea was observed in 49 (21%) patients. Patients with diarrhoea were older and were more likely to have comorbidities than patients without diarrhoea (table). A greater proportion of patients admitted to hospital had diarrhoea as the outbreak progressed: nine (43%) of 21 patients admitted between Feb 12 and March 6, 2020, had diarrhoea versus 40 (19%) of 209 patients admitted between Jan 19 and Feb 11, 2020.TableDemographic and clinical characteristics of patients with COVID-19 with and without diarrhoeaWith diarrhoea (n=49)Without diarrhoea (n=181)p valueAge, years55 (40–65)46 (36–57)0·017Sex....0·87Male27 (55%)102 (56%)..Female22 (45%)79 (44%)..Any comorbidity19 (39%)39 (22%)0·017Date of admission to hospital....0·022Jan 19–Feb 11, 202040 (82%)169 (93%)..Feb 12–March 6, 20209 (18%)12 (7%)..Severe COVID-19 disease26 (53%)35 (19%)<0·0001Oxygen supplementation44 (90%)143 (79%)0·10Ventilatory support6 (12%)3 (2%)0·0036Intensive care15 (31%)20 (11%)0·0015Died4 (8%)2 (1%)0·020White blood cell count, ×109 cells per L5·6 (2·0)5·6 (3·0)1·0Lymphocyte count, ×109 cells per L1·0 (0·6)1·1 (0·5)0·28Neutrophil count, ×109 cells per L3·4 (1·8)3·9 (2·9)0·34Alanine aminotransferase, U/L37·9 (27·4)34·0 (24·4)0·36Aspartate aminotransferase, U/L39·3 (27·0)34·7 (17·9)0·19Total bilirubin, μmol/L12·5 (7·3)11·5 (5·9)0·36Activated partial thromboplastin time, s30·5 (9·5)31·0 (7·8)0·74D-dimer, mg/L1·0 (1·8)1·6 (5·4)0·48Procalcitonin, ng/mL0·29 (0·69)0·19 (0·36)0·25Erythrocyte sedimentation rate, mm/h40·7 (30·0)23·8 (18·7)0·0002C-reactive protein, mg/L40·5 (52·0)30·0 (38·3)0·16Antibiotics36 (73%)138 (76%)0·71Antiviral treatment49 (100%)180 (99%)1·0Data are median (IQR), n (%), or mean (SD). p values comparing patients with and without diarrhoea were calculated by use of Fisher's exact test, Mann–Whitney U test, or Student's t test. COVID-19=coronavirus disease 2019. Open table in a new tab Data are median (IQR), n (%), or mean (SD). p values comparing patients with and without diarrhoea were calculated by use of Fisher's exact test, Mann–Whitney U test, or Student's t test. COVID-19=coronavirus disease 2019. More patients with diarrhoea showed severe symptoms of pneumonia than those without diarrhoea, with an adjusted (for age, sex, and comorbidities) odds ratio (OR) of 4·95 (95% CI 2·14–11·70, p=0·0002). Although there was no correlation between diarrhoea and oxygen supplementation, a greater proportion of patients with diarrhoea required ventilator support (adjusted OR 6·52 [95% CI 1·44–35·86], p=0·018) and required admission to intensive care (3·19 [1·25–8·16], p=0·015). Most laboratory test results did not differ significantly between patients with and without diarrhoea (table). A similar proportion of patients with and without diarrhoea were given antibiotics and antiviral medications (table). Less frequent gastrointestinal symptoms included bloody stool (ten [4%] of 230 patients) and abdominal pain (three [1%] of 230 patients). No patients presented with gastrointestinal symptoms alone, which might reflect the recommendation for patients with mild symptoms to stay at home. Our observations of patients with COVID-19 from medical centres within and outside of Hubei province (appendix pp 3–5) are consistent with other reports3Holshue ML DeBolt C Lindquist S et al.First case of 2019 novel coronavirus in the United States.N Engl J Med. 2020; 382: 929-936Crossref PubMed Scopus (4303) Google Scholar, 4Zhang W Du RH Li B et al.Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes.Emerg Microbes Infect. 2020; 9: 386-389Crossref PubMed Scopus (1326) Google Scholar, 5Wang W Xu Y Gao R et al.Detection of SARS-CoV-2 in different types of clinical specimens.JAMA. 2020; (published online March 11.)DOI:10.1001/jama.2020.3786Crossref Scopus (3798) Google Scholar, 6Xiao F Tang M Zheng X Liu Y Li X Shan H Evidence for gastrointestinal infection of SARS-CoV-2.Gastroenterology. 2020; (published online March 3.)DOI:10.1053/j.gastro.2020.02.055Summary Full Text Full Text PDF Scopus (2024) Google Scholar, 7Pan L Mu M Yang P et al.Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study.Am J Gastroenterol. 2020; (published online March 18, 2020.) (preprint).https://journals.lww.com/ajg/Documents/COVID_Digestive_Symptoms_AJG_Preproof.pdf?PRID=AJG_PR_031820Crossref PubMed Scopus (1200) Google Scholar, 8Luo S Zhang X Xu H Don't overlook digestive symptoms in patients with 2019 novel coronavirus disease (COVID-19).Clin Gastroenterol Hepatol. 2020; (published online March 20.)doi:10.1016/j.cgh.2020.03.043Summary Full Text Full Text PDF Scopus (253) Google Scholar, 9Fang D Ma J Guan J et al.Manifestations of digestive system in hospitalized patients with novel coronavirus pneumonia in Wuhan, China: a single-center, descriptive study.Chin J Dig. 2020; (published online Feb 23.)DOI:10.3760/cma.j.issn.0254-1432.2020.0005Google Scholar showing gastrointestinal involvement in COVID-19. Many of these studies3Holshue ML DeBolt C Lindquist S et al.First case of 2019 novel coronavirus in the United States.N Engl J Med. 2020; 382: 929-936Crossref PubMed Scopus (4303) Google Scholar, 4Zhang W Du RH Li B et al.Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes.Emerg Microbes Infect. 2020; 9: 386-389Crossref PubMed Scopus (1326) Google Scholar, 5Wang W Xu Y Gao R et al.Detection of SARS-CoV-2 in different types of clinical specimens.JAMA. 2020; (published online March 11.)DOI:10.1001/jama.2020.3786Crossref Scopus (3798) Google Scholar, 6Xiao F Tang M Zheng X Liu Y Li X Shan H Evidence for gastrointestinal infection of SARS-CoV-2.Gastroenterology. 2020; (published online March 3.)DOI:10.1053/j.gastro.2020.02.055Summary Full Text Full Text PDF Scopus (2024) Google Scholar, 7Pan L Mu M Yang P et al.Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study.Am J Gastroenterol. 2020; (published online March 18, 2020.) (preprint).https://journals.lww.com/ajg/Documents/COVID_Digestive_Symptoms_AJG_Preproof.pdf?PRID=AJG_PR_031820Crossref PubMed Scopus (1200) Google Scholar, 8Luo S Zhang X Xu H Don't overlook digestive symptoms in patients with 2019 novel coronavirus disease (COVID-19).Clin Gastroenterol Hepatol. 2020; (published online March 20.)doi:10.1016/j.cgh.2020.03.043Summary Full Text Full Text PDF Scopus (253) Google Scholar, 9Fang D Ma J Guan J et al.Manifestations of digestive system in hospitalized patients with novel coronavirus pneumonia in Wuhan, China: a single-center, descriptive study.Chin J Dig. 2020; (published online Feb 23.)DOI:10.3760/cma.j.issn.0254-1432.2020.0005Google Scholar reported patients with COVID-19 who only had gastrointestinal symptoms during the course of the illness, and another study2Wang D Hu B Hu C et al.Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China.JAMA. 2020; (published online Feb 7.)DOI:10.1001/jama.2020.1585Crossref Scopus (16307) Google Scholar reported patients with COVID-19 who presented with diarrhoea 1–2 days before the development of fever and dyspnoea. We noted correlations between the presence of diarrhoea and the severity of respiratory symptoms, and found that more patients with diarrhoea required ventilator support and were admitted to intensive care than those without diarrhoea. Similarly, during the SARS outbreak in 2003, more patients with SARS who had diarrhoea required ventilator support and were admitted to intensive care than those who did not have diarrhoea.10Leung WK To KF Chan PK et al.Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection.Gastroenterology. 2003; 125: 1011-1017Summary Full Text Full Text PDF PubMed Scopus (548) Google Scholar Understanding the mechanism underlying these correlations could help to identify novel intervention strategies to reduce or prevent severe outcomes of COVID-19. The proportion of patients with COVID-19 who had gastrointestinal symptoms in our analysis (21% with diarrhoea) is higher than that observed in earlier reports (2–3% with diarrhoea1Chen N Zhou M Dong X et al.Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.Lancet. 2020; 395: 507-513Summary Full Text Full Text PDF PubMed Scopus (14440) Google Scholar, 11Huang C Wang Y Li X et al.Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.Lancet. 2020; 395: 497-506Summary Full Text Full Text PDF PubMed Scopus (33099) Google Scholar). Similarly, a greater proportion of patients admitted to hospital had diarrhoea as the outbreak progressed. This difference could be due to a heightened awareness of the gastrointestinal symptoms of COVID-19 among clinicians. Additionally, the passing of time could have allowed the virus to accumulate mutations that might have affected its tropism for the intestines. The difference could also reflect geographic differences between populations studied (ie, early studies from Wuhan vs our patients from four other cities). The increasing number of patients with COVID-19 who have gastrointestinal symptoms warrants further study. A potential limitation of our analysis is the absence of data on the prevalence of asymptomatic COVID-19. It is likely that more asymptomatic patients existed, leading to an overestimation of the proportion of patients with gastrointestinal symptoms. Another possible confounding factor is that the antivirals, lopinavir and ritonavir, are known to cause diarrhoea. However, we did not observe a correlation between diarrhoea and use of antiviral medicine or antibiotics. All authors declare no competing interests. This work was partially supported by National Natural Science Foundation of China 81770571 (to LZ), 81970452 (to PL), 81774152 (to RZ), the Guangzhou Science and Technology Plan Projects 201803040019 (to PL), and the Key Projects of Dongguan City Social Science and Technology Development Plan 201750715001464 (to LS). YW, JL, LS, YZ, LH, and LZ contributed equally; LZ, GY, RZ, and PL are joint senior authors. Download .pdf (.77 MB) Help with pdf files Supplementary appendix Download .pdf (.53 MB) Help with pdf files Chinese translation of full text

Letter: Prevalence and Patterns of Gastrointestinal Symptoms in a Large Western Cohort of Patients with Coronavirus Disease 2019—authors' Reply

Letter: Gastrointestinal Symptoms Pre‐admission Are Associated with Greater Severity of COVID‐19—authors' Reply

Letter: prevalence and patterns of gastrointestinal symptoms in a large Western cohort of patients with COVID-19

Primary Care Practitioners' Response to 2019 Novel Coronavirus Outbreak in China

Alterations of the Gut Microbiota in Patients with Coronavirus Disease 2019 or H1N1 Influenza.

Epidemiological, Clinical and Virological Characteristics of 74 Cases of Coronavirus-Infected Disease 2019 (COVID-19) with Gastrointestinal Symptoms

The Prevalence of Gastrointestinal Symptoms, Abnormal Liver Function, Digestive System Disease and Liver Disease in COVID-19 Infection

Gut mycobiota alterations in patients with COVID-19 and H1N1 and associations with immune and gastrointestinal symptoms

Comparison of Laboratory Characteristics of Gastrointestinal Symptoms and Nongastrointestinal Symptoms in Patients Infected with COVID-19: a Systematic Review and Meta-Analysis

Clinical characteristics of coronavirus disease (COVID-19) patients with gastrointestinal symptoms: A report of 164 cases

Gastrointestinal manifestations in symptomatic Coronavirus disease - 19 patients and its relevance in predicting severity and outcome

Intestinal Host Response to SARS-CoV-2 Infection and COVID-19 Outcomes in Patients With Gastrointestinal Symptoms

Digestive system manifestations and clinical significance of coronavirus disease 2019: A systematic literature review

Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples From a Hong Kong Cohort: Systematic Review and Meta-analysis

Review Article: Gastrointestinal Features in COVID‐19 and the Possibility of Faecal Transmission

Digestive Manifestations in Patients Hospitalized With Coronavirus Disease 2019

Gut Mycobiota Alterations in Patients with COVID-19 and H1N1 Infections and Their Associations with Clinical Features

Gastrointestinal Symptoms Are Associated with Severity of Coronavirus Disease 2019: a Systematic Review and Meta-Analysis

Probiotics and COVID-19 – Authors' Reply

Enteric Involvement in Hospitalised Patients with COVID-19 Outside Wuhan

Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission